Skip to content

Main Navigation

Clinical Study

Improving Health of Children with MS

Kesimpta® and Mayzent® are potential medications for children with Multiple Sclerosis (MS). Scientists and doctors need to learn the safety and effectiveness of these medications to improve the health of children with MS.

I AM INTERESTED

For more information contact:

Trieste Francis

  trieste.francis@hsc.utah.edu
  801-587-3864

IRB#: IRB_00145728 | PI: M. Mateo Paz Soldan | Department: NEUROLOGY | Approval Date: 2022-04-13 06:00:00
Study Categories: Brain Health Studies | Specialties: Neurology

Who can participate?

 Gender: All

 Age: Over 7 years old

 Volunteers: Volunteers with special conditions

 Location: In Person


Inclusion Criteria:

  • Between 10-18 years old
  • A formal Pediatric MS diagnosis
  • At least one MS relapse/attack during the previous year OR two MS relapses total in the previous two years

Will I be paid for my time?

Yes

Last Updated: 4/5/21